首页 | 本学科首页   官方微博 | 高级检索  
     检索      


Comparison of efficacy and toxicity of doxorubicin and mitoxantrone in combination chemotherapy for canine lymphoma
Authors:Shang-Lin Wang  Jih-Jong Lee  Albert Taiching Liao
Institution:National Taiwan University Veterinary Hospital, College of Bioresources and Agriculture (Wang), Department and Graduate Institute of Veterinary Medicine, School of Veterinary Medicine (Wang, Liao), Graduate Institute of Veterinary Clinical Science, School of Veterinary Medicine (Lee), Animal Cancer Center, College of Bioresources and Agriculture (Lee, Liao), National Taiwan University, Taipei, 10672, Taiwan, Republic of China
Abstract:Forty-four dogs with multicentric lymphoma were treated using a cyclophosphamide, doxorubicin, vincristine, and prednisolone (CHOP) induction protocol or treated using a cyclophosphamide, mitoxantrone, vincristine, and prednisolone (CMOP) induction protocol. There was no statistical difference in signalment and the presence of historical negative prognostic factors between the groups. The median progression-free survival (PFS) in the CHOP and CMOP groups were 222 d and 162 d, respectively (P = 0.75). The median survival time (MST) of dogs in CHOP and CMOP groups were 318 d and 242 d, respectively (P = 0.63). Anorexia and diarrhea episodes were significantly higher in the CHOP group than in the CMOP group (P = 0.02 and P = 0.01, respectively). These results suggest that the CMOP protocol provides similar PFS, MST and causes fewer side effects compared to the CHOP protocol. Therefore, the CMOP protocol may be another treatment choice for canine multicentric lymphoma.
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号